EKF Diagnostics, worldwide manufacturer of point-of-care diagnostic tools, organ injury biomarkers and assays, has announced the launch of a new division to focus on molecular and companion diagnostics.
Vendors exhibiting strong leadership and understanding of interoperability standards to make gains
The 2013 turnover expected by German in vitro diagnostics producers are significantly lower compared to last year, according to a survey of members carried out by the German Diagnostics Industry Association (VDGH) presented in January at the Diagnostica Forum in Berlin.
Massive and increasing cost pressure urges many hospitals to look for alternatives to expensive in-patient surgery.
Management in Radiology (MIR): this ESR subcommittee is dedicated to management topics, developments in eHealth, and major trends in the discipline.
The second Management in Radiology session at this year’s ECR focussed on challenges for radiology coming from telemedicine, eHealth, appropriateness, and safety issues.
New business ventures, new systems – and those include 3-D mammography
The last decade saw PET and now PET/CT numbers expand rapidly in Europe. More recently the picture has been less rosy with public and private sectors delaying new projects and pushing back the replacement of equipment.
Aspects of new healthcare legislation are causing concern among medical laboratory experts in the United Kingdom – including the lack of future funding for innovation and development under a new reimbursement model, little appetite to quantify the cost effectiveness of laboratory testing, reduced staffing and a shift in emphasis that will see the need to make profit over-ride initiative and…
A new test gives reliable results in just 75 minutes, speeding up combat actions. Since Methicillin-resistant staphy lococcus aureus (MRSA) has developed resistance to antibiotic treatments, infections have become a dreaded occurrence in hospitals worldwide.
Julian Baines, Group CEO of EKF Diagnostics Holdings plc, considers the present role of point of-care tests and their potential value to health services
Late last year, at the German Hospital Procurement Congress in Berlin, we met with Durral R Gilbert, President of the US firm Premier Supply Chain Services, who was presenting cost-cutting strategies that reach far beyond reducing consumables and equipment prices – strategies that might also help hospitals in Europe.
Founded in 1991 in Shenzhen, China, Mindray is now known internationally for its products that cover patient monitoring and life support, in-vitro diagnostics, medical imaging and veterinary. During Daniela Zimmermann’s interview with David Yin, General Manager of Mindray Europe, he described the firm’s clear strategy for Europe and beyond
In its bid to offer the most modern medicine program in Sweden, Örebro University has invested in three visualization tables from Sectra.
A high unemployment rate coupled with an influx of refugees from Iraq and Syria has compounded challenges faced by the Jordanian government to provide healthcare for all, states a new report by healthcare experts GlobalData.
The investment company Aurelius Group, based in Munich/Germany, has closed a deal to acquire Tieto’s divisions Healthcare, Systems Integration & Consulting, and Product Engineering Solutions as well as related activities in the Netherlands, Poland, and India.
Bioelectrical impedance analysis (BIA) supports physicians in vital treatment decisions.
Olympus has led the field in advancing endoscopic technology. Just when experts and users thought no further optimisation was possible, Olympus placed another major innovation in the marketplace – and the firm has done it again.
Robotics and systems providing assistance during procedures harbor great potential for medical use.
A prototype for proton and ion therapy has been used clinically in Heidelberg since 2009. Built jointly by Siemens and GSI (Helmholtz Centre for Heavy Ion Research) in Darmstadt.
The German Medical Technology Association BVMed is asking the European Commission, the Council and the Parliament to take immediate action in bringing forward appropriate measures to improve the designation and surveillance of notified bodies and market surveillance of medical devices.
No one wants to be admitted to a hospital because the food is good. Yet, following discharge, one of the first things the patient is asked is, ‘How was the food?’ as if the medical treatment is of secondary interest.
The formation of the National Institute for Health Research has made the field vastly stronger and the country is now placed second only to the USA, reports Mark Nicholls
Erlangen’s CSC RIS streams data through workplaces, speeds up reports and patient care, so, what’s next – greater mobility and transmission to a Cloud?
With a mission to help people avoid unnecessary radiation, and the continuing launch of related products, the Swedish company is now the world’s only provider of comprehensive solutions to measure, monitor and manage X-ray radiation dose, reports Brenda Marsh